環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法)
Multiplex Assay Kit for Cyclooxygenase-2 (COX 2) ,etc. by CBA (Cytometric Bead Array)
PGG/HS; PGHS2; PHS2; HCox2; PTGS2; Prostaglandin Endoperoxide Synthase 2; Prostaglandin G/H Synthase And Cyclooxygenase; Prostaglandin H2 synthase 2
- 編號(hào)CMA699Mu
- 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
- 實(shí)驗(yàn)方法雙抗夾心
- 反應(yīng)時(shí)長(zhǎng)4h
- 檢測(cè)范圍4.8828-5000pg/mL
- 靈敏度最小可檢測(cè)劑量小于等于1.6276pg/mL.
- 樣本類型Serum, plasma and other biological fluids
- 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格48T96T
- 價(jià)格¥ 3268¥ 4668
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測(cè)環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法),經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來(lái)源的限制,不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè),因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法)(加標(biāo)樣品),重復(fù)測(cè)定并計(jì)算其均值,回收率為測(cè)定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) |
| serum(n=5) | 82-101 | 89 |
| EDTA plasma(n=5) | 89-103 | 92 |
| heparin plasma(n=5) | 88-96 | 91 |
精密度
精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
批間差:選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定,每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法),并倍比稀釋成1:2,1:4,1:8,1:16的待測(cè)樣本,線性范圍即為稀釋后樣本中環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法)含量的測(cè)定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 92-103% | 78-103% | 84-105% | 79-92% |
| EDTA plasma(n=5) | 93-102% | 80-104% | 91-99% | 83-102% |
| heparin plasma(n=5) | 94-102% | 95-102% | 78-103% | 90-99% |
穩(wěn)定性
經(jīng)測(cè)定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1、向?qū)嶒?yàn)板每孔內(nèi)加入200μL分析緩沖液以預(yù)濕;
2、實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本準(zhǔn)備;
3、加樣(標(biāo)準(zhǔn)品、樣本、磁珠),標(biāo)準(zhǔn)品或樣本100μL及磁珠10μL,25°C酶標(biāo)板振蕩器孵育2小時(shí);
4、磁吸甩干,加檢測(cè)溶液A 100μL,25°C酶標(biāo)板振蕩器孵育1小時(shí);
5、磁吸甩干,加檢測(cè)溶液B 100μL,25°C振動(dòng)孵育30分鐘;
6、磁吸洗板1次;
7、加鞘液100μL,旋渦震蕩10分鐘后讀數(shù)。
實(shí)驗(yàn)原理
將環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法)抗體包被于磁性微球表面,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本以及磁珠,其中的環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法)抗體,加入PE標(biāo)記的親和素,用流式細(xì)胞儀讀數(shù)。MFI值和樣品中的環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法)濃度呈正相關(guān)。
贈(zèng)品
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
| RPA699Mu02 | 環(huán)加氧酶2(COX 2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA699Mu01 | 環(huán)加氧酶2(COX 2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA699Mu01 | 環(huán)加氧酶2(COX 2)多克隆抗體 | WB; IHC |
| PAA699Mu02 | 環(huán)加氧酶2(COX 2)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA699Mu81 | 環(huán)加氧酶2(COX 2)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAA699Mu71 | 環(huán)加氧酶2(COX 2)多克隆抗體(生物素標(biāo)記) | WB |
| SEA699Mu | 環(huán)加氧酶2(COX 2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA699Mu | 環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| CMA699Mu | 環(huán)加氧酶2(COX 2)等多因子檢測(cè)試劑盒(流式熒光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Photodermatology, Photoimmunology & Photomedicine | Diallyl sulfide protects against ultraviolet B-induced skin cancers in SKH-1 hairless mouse: analysis of early molecular events in carcinogenesis[Wiley: source] |
| Skin Cancer - MedlinePlus Health Information | Molecular mechanisms underlying chemopreventive activities of glycyrrhizic acid against UVB-radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis[PubMed: 21545294] |
| Evidence-Based Complementary and Alternative Medicine | Curcumin Protects against UVB-Induced Skin Cancers in SKH-1 Hairless Mouse: Analysis of Early Molecular Markers in Carcinogenesis[PubMed: 22888366] |
| Integrative Cancer Therapies | Decalepis hamiltonii inhibits tumor progression and metastasis by regulating the inflammatory mediators and nuclear factor κB subunits[Pubmed: 24013642] |
| Journal of ethnopharmacology | Multitargeted protective effect of Abacopteris penangiana against carrageenan-induced chronic prostatitis in rats.[Pubmed: 24211397] |
| Int J Clin Exp Pathol | Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells[PubMed: 26464643] |
| Int J Clin Exp Pathol | Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma[PubMed: 26191267] |
| Journal of Biomechanics | The shear wave elastic modulus and the increased nuclear factor kappa B(NF-kB/p65) and cyclooxygenase-2 (COX-2) expression in the area of myofascial trigger points activated in a rat model by blunt trauma to the vastus medialis[pubmed:29137729] |
| Journal of Global Pharma Technology | Inflammatory Response of Annona Muricata Linn Leaves Extract in Colorectal Cancer Patients[NCT02439580] |
| International?Journal?of?Molecular?Sciences | High Expression of IL-1RI and EP2 Receptors in the IL-1β/COX-2 Pathway, and a New Alternative to Non-Steroidal Drugs—Osthole in Inhibition COX-2[Pubmed: 30620999] |
| International Immunopharmacology | A novel concept of immunological and allergy interactions in Autism Spectrum Disorders: Molecular, anti-inflammatory effect of osthole[Pubmed: 30953868] |
| Reports of Biochemistry & Molecular Biology | Evaluation of Serum Cyclooxygenase, Hepcidin Levels in Acute Renal Injury (AKI) Patients Following Cardiac Catheterization[] |
| J Ethnopharmacol | Isolation and characterization of anti-inflammatory and anti-proliferative compound, for B-cell Non-Hodgkin lymphoma, from Nyctanthes arbor-tristis Linn.[Pubmed:35398498] |


